Revance raises $150M in follow-on

Revance Therapeutics Inc. (NASDAQ:RVNC) raised $150 million on Dec. 7 through the sale of 4.8 million shares at $31 in a follow-on underwritten by Goldman Sachs, Cowen, Barclays, Cantor Fitzgerald, William Blair and SunTrust Robinson Humphrey. The price is an 11% discount from Revance's close of $34.75 on Dec. 5, when it proposed after market hours to raise $175 million...